相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and tolerability of tapentadol for the treatment of chronic low back pain in elderly patients
Ulderico Freo et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)
A Review of the Food and Drug Administration Adverse Event Reporting System for Tramadol-Related Hypoglycemia
Katherine M. Juba et al.
ANNALS OF PHARMACOTHERAPY (2020)
Opioids for chronic non-cancer neuropathic pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration
Claudia Sommer et al.
EUROPEAN JOURNAL OF PAIN (2020)
The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review
Brian A. Baldo et al.
BRITISH JOURNAL OF ANAESTHESIA (2020)
Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs
Uazman Alam et al.
DRUGS (2020)
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee
Sharon L. Kolasinski et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Tapentadol Prolonged Release for Severe Chronic Osteoarthritis Pain in the Elderly-A Subgroup Analysis of Routine Clinical Practice Data
Andreas Schwittay et al.
PAIN RESEARCH & MANAGEMENT (2020)
Tapentadol prolonged release for severe chronic osteoarthritis pain in the elderly: improvements in daily functioning and quality of life
Kai-Uwe Kern et al.
PAIN MANAGEMENT (2020)
Efficacy of Tramadol for Pain Management in Patients Receiving Strong Cytochrome P450 2D6 Inhibitors
Derek A. Frost et al.
PHARMACOTHERAPY (2019)
Chronic use of tramadol after acute pain episode: cohort study
Cornelius A. Thiels et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Opioid Management in Older Adults with Chronic Kidney Disease: A Review
Montgomery T. Owsiany et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Comparative study of hypoglycaemia induced by opioids. Is it a class effect?
Basile Chretien et al.
EXPERT OPINION ON DRUG SAFETY (2019)
A Comprehensive Algorithm for Management of Neuropathic Pain
Daniel Bates et al.
PAIN MEDICINE (2019)
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids
Keith M. Olson et al.
PLOS ONE (2019)
Letter to the editor: hypoglycemia and treatment with opioids
Jan Broz et al.
EXPERT OPINION ON DRUG SAFETY (2019)
Serotonin syndrome masquerading as disease flare in lupus nephritis with end-stage renal disease
Rodeo Navarroza et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2019)
Tramadol Hydrochloride at Steady State Lacks Clinically Relevant QTc Interval Increases in Healthy Adults
Joseph Massarella et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome
Anna Rickli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Comparative pharmacology and toxicology of tramadol and tapentadol
J. Faria et al.
EUROPEAN JOURNAL OF PAIN (2018)
Writing in Order Not to Die: Testimony and Writing in the Work of Carlos Liscano
Claudia Gutierrez Olivares
ESTUDIOS AVANZADOS (2018)
Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System
Suzanne K. Vosburg et al.
JOURNAL OF PAIN (2018)
Does Strong Analgesic' Equal Strong Opioid'? Tapentadol and the Concept of μ-Load'
Robert B. Raffa et al.
ADVANCES IN THERAPY (2018)
Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trials
Bernd Lange et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Vomiting and constipation associated with tramadol and codeine: a comparative study in VigiBase®
Francois Montastruc et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Designing safer analgesics: a focus on μ-opioid receptor pathways
Joseph V. Pergolizzi et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Opioids for Chronic Noncancer Pain A Systematic Review and Meta-analysis
Jason W. Busse et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview
Crystian B. Oliveira et al.
EUROPEAN SPINE JOURNAL (2018)
Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic
Ariane Stollenwerk et al.
ADVANCES IN THERAPY (2018)
Serious adverse drug reactions with tramadol reported to the French pharmacovigilance database between 2011 and 2015
Florence Moulis et al.
THERAPIE (2017)
Acute administration of tramadol and tapentadol at effective analgesic and maximum tolerated doses causes hepato- and nephrotoxic effects in Wistar rats
Joana Barbosa et al.
TOXICOLOGY (2017)
Effective analgesic doses of tramadol or tapentadol induce brain, lung and heart toxicity in Wistar rats
Juliana Faria et al.
TOXICOLOGY (2017)
Tapentadol for Cancer Pain Management: A Narrative Review
Alberto Carmona-Bayonas et al.
PAIN PRACTICE (2017)
Efficacy of Tramadol Extended-Release for Opioid Withdrawal A Randomized Clinical Trial
Kelly E. Dunn et al.
JAMA PSYCHIATRY (2017)
Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research
Laura E. Gressler et al.
JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY (2017)
An experimental study comparing the respiratory effects of tapentadol and oxycodone in healthy volunteers
R. van der Schrier et al.
BRITISH JOURNAL OF ANAESTHESIA (2017)
Safety, Tolerability, and Pharmacokinetics of Therapeutic and Supratherapeutic Doses of Tramadol Hydrochloride in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Multiple-Ascending-Dose Study
Byron DeLemos et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Cardiac Arrest Following Drug Abuse with Intravenous Tapentadol: Case Report and Literature Review
Misbahuddin Khaja et al.
AMERICAN JOURNAL OF CASE REPORTS (2017)
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2017)
Opioid Pharmacokinetics-Pharmacodynamics: Clinical Implications in Acute Pain Management in Trauma
Meghan MacKenzie et al.
ANNALS OF PHARMACOTHERAPY (2016)
Comparative metabolism of tramadol and tapentadol: a toxicological perspective
Joana Barbosa et al.
DRUG METABOLISM REVIEWS (2016)
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
Elena Bandieri et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council
Roger Chou et al.
JOURNAL OF PAIN (2016)
Economic evaluation in chronic pain: a systematic review and de novo flexible economic model
W. Sullivan et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2016)
Comparative Toxicity of Tapentadol and Tramadol Utilizing Data Reported to the National Poison Data System
Ben T. Tsutaoka et al.
ANNALS OF PHARMACOTHERAPY (2015)
Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?
Felicity C. Veal et al.
DRUGS & AGING (2015)
Pharmacokinetics of Tramadol and O-Desmethyltramadol Enantiomers Following Administration of Extended-Release Tablets to Elderly and Young Subjects
Sybil Skinner-Robertson et al.
DRUGS & AGING (2015)
Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol
Tuukka Saarikoski et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Tapentadol prolonged release in the treatment of neuropathic pain related to diabetic polyneuropathy Reply
Nanna B. Finnerup et al.
LANCET NEUROLOGY (2015)
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Nanna B. Finnerup et al.
LANCET NEUROLOGY (2015)
Tapentadol Abuse Potential: A Postmarketing Evaluation Using a Sample of Individuals Evaluated for Substance Abuse Treatment
Stephen F. Butler et al.
PAIN MEDICINE (2015)
Comparing tapentadol to oxycodone/naloxone combination: building castles in the air
Carmelo Scarpignato et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor-related Pain on Other Opioids to Tapentadol Extended Release
Keiichiro Imanaka et al.
CLINICAL DRUG INVESTIGATION (2014)
Evaluation of Blood Pressure and Heart Rate in Patients with Hypertension Who Received Tapentadol Extended Release for Chronic Pain: A Post Hoc, Pooled Data Analysis
David M. Biondi et al.
CLINICAL DRUG INVESTIGATION (2014)
Nonmedical Use of Tapentadol Immediate Release by College Students
Richard C. Dart et al.
CLINICAL JOURNAL OF PAIN (2014)
Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain
Flaminia Coluzzi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
The clinical analgesic efficacy of buprenorphine
R. B. Raffa et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy
Bansri Desai et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
Tapentadol Prolonged Release Versus Strong Opioids for Severe, Chronic Low Back Pain: Results of an Open-Label, Phase 3b Study
Rafael Galvez et al.
ADVANCES IN THERAPY (2013)
Budget Impact Analysis of Tapentadol Extended Release for the Treatment of Moderate to Severe Chronic Noncancer Pain
Sanjay Merchant et al.
CLINICAL THERAPEUTICS (2013)
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids
Sebastiano Mercadante et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain
Keiichiro Imanaka et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Rifampicin markedly decreases the exposure to oral and intravenous tramadol
Tuukka Saarikoski et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations
Karin Goehler et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Tapentadol Analgesic Interaction with Clonidine
Paula Sanders
PAIN MEDICINE (2013)
Mu Opioids and Their Receptors: Evolution of a Concept
Gavril W. Pasternak et al.
PHARMACOLOGICAL REVIEWS (2013)
Cost-Effectiveness of Tapentadol in Severe Chronic Pain in Spain: A Cost Analysis of Data From RCTs
Marko Obradovic et al.
CLINICAL THERAPEUTICS (2012)
Analgesics in Patients with Hepatic Impairment Pharmacology and Clinical Implications
Marija Bosilkovska et al.
DRUGS (2012)
Treatment of Chronic Pain in Older People
Annette L. van Ojik et al.
DRUGS & AGING (2012)
Randomized controlled trial of the combined monoaminergic and opioid investigational compound GRT9906 in painful polyneuropathy
S. H. Sindrup et al.
EUROPEAN JOURNAL OF PAIN (2012)
Mechanistic and functional differentiation of tapentadol and tramadol
Robert B. Raffa et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Clinical simulation model of long-acting opioids for treatment of chronic non-cancer pain in the United States
Nancy Neil et al.
JOURNAL OF MEDICAL ECONOMICS (2012)
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine
Robert Ikenberg et al.
JOURNAL OF MEDICAL ECONOMICS (2012)
Pharmacogenetics: From Bench to Byte-An Update of Guidelines
J. J. Swen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Tapentadol in Pain Management A mu-Opioid Receptor Agonist and Noradrenaline Reuptake Inhibitor
Craig T. Hartrick et al.
CNS DRUGS (2011)
A thorough QT/QTc study of multiple doses of tapentadol immediate release in healthy subjects
C. Oh et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
The analgesic tramadol has minimal effect on gastrointestinal motor function
Clive H. Wilder-Smith et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee A Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Study
Marc Afilalo et al.
CLINICAL DRUG INVESTIGATION (2010)
Cost-Effectiveness Analysis of Tapentadol Immediate Release for the Treatment of Acute Pain
W. Jacqueline Kwong et al.
CLINICAL THERAPEUTICS (2010)
Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study
Robert Buynak et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
The impact of tramadol and dihydrocodeine treatment on quality of life of patients with cancer pain
W. Leppert et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
IN VITRO AND IN VIVO CHARACTERIZATION OF TAPENTADOL METABOLITES
R. Terlinden et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2010)
Tramadol in Neuropathic Pain After Spinal Cord Injury A Randomized, Double-blind, Placebo-controlled Trial
Cecilia Norrbrink et al.
CLINICAL JOURNAL OF PAIN (2009)
Establishing Best Practices for Opioid Rotation: Conclusions of an Expert Panel
Perry G. Fine et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)
Antidepressants for the Treatment of Chronic Pain
Benedicte Verdu et al.
DRUGS (2008)
(-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (Tapentadol HCl):: a novel μ-opioid receptor agonist norepinephrine Reuptake inhibitor with broad-spectrum analgesic properties
Thomas M. Tzschentke et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
A comparison of the analgesic efficacy of tramadol contramid OAD versus placebo in patients with pain due to osteoarthritis
Francis Burch et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2007)
Absorption, metabolism, and excretion of 14C-labeled Tapentadol HCl in healthy male subjects
Rolf Terlinden et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2007)
Incidence of weak Opioids adverse events in the management of cancer pain: A double-blind comparative trial
Rene Fernando Rodriguez et al.
JOURNAL OF PALLIATIVE MEDICINE (2007)
Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients
Gary Vorsanger et al.
CLINICAL THERAPEUTICS (2007)
Genetic polymorphism and drug interactions: their importance in the treatment of pain
CF Samer et al.
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2005)
The effects of tramadol on static and dynamic pupillometry in healthy subjects-the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status
F Fliegert et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Treatment of pain in patients with renal insufficiency: The world health organization three-step ladder adapted
V Launay-Vacher et al.
JOURNAL OF PAIN (2005)
The median effective dose of tramadol and morphine for postoperative patients: A study of interactions
TA Marcou et al.
ANESTHESIA AND ANALGESIA (2005)
Tramadol SR formulations - Pharmacokinetic comparison of a multiple-units dose (capsule) versus a single-unit dose (tablet)
PJ Cnota et al.
CLINICAL DRUG INVESTIGATION (2005)
Tramadol/acetaminophen combination tablets for the treatment of pain associated with osteoarthritis flare in an elderly patient population
NR Rosenthal et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: A multicenter, randomized, double-blind, placebo-controlled study
H Malonne et al.
CLINICAL THERAPEUTICS (2004)
Clinical pharmacology of tramadol
S Grond et al.
CLINICAL PHARMACOKINETICS (2004)
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants
LD Bradford
PHARMACOGENOMICS (2002)
Influence of oral tramadol on the dynamic ventilatory response to carbon dioxide in healthy volunteers
D Nieuwenhuijs et al.
BRITISH JOURNAL OF ANAESTHESIA (2001)
Tramadol - A review of its use in perioperative pain
LJ Scott et al.
DRUGS (2000)
分享论文
